Abstract
Sixteen patients with ophthalmic Graves' disease (clinically euthyroid with ophthalmopathy or exophthalmos) were followed up for 4.3 to 14.3 (mean 9.1) years to determine whether thyroid dysfunction developed and whether their ophthalmopathy progressed, regressed or remained stable. Five patients (31%) manifested hyperthyroidism or hypothyroidism, all before the end of the fifth year of follow-up. The ophthalmopathy was mild, and none of the patients required specific treatment. The thyroid function of patients with ophthalmic Graves' disease should be periodically monitored for at least 5 years.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brownlie B. E., Newton O. A., Singh S. P. Ophthalmopathy associated with primary hypothyroidism. Acta Endocrinol (Copenh) 1975 Aug;79(4):691–699. doi: 10.1530/acta.0.0790691. [DOI] [PubMed] [Google Scholar]
- Burke G. The triiodothyronine suppression test. Am J Med. 1967 Apr;42(4):600–608. doi: 10.1016/0002-9343(67)90058-7. [DOI] [PubMed] [Google Scholar]
- Cennamo G., Bizzarro A., Soricelli A., Dendi B., Bonavolontà G. Correlation between unilateral exophthalmos and thyroid diseases. Ophthalmologica. 1980;180(4):216–220. doi: 10.1159/000308977. [DOI] [PubMed] [Google Scholar]
- Donaldson S. S., Bagshaw M. A., Kriss J. P. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab. 1973 Aug;37(2):276–285. doi: 10.1210/jcem-37-2-276. [DOI] [PubMed] [Google Scholar]
- Easton P. A., Wall J. R. Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine. Can Med Assoc J. 1981 Jul 1;125(1):65–66. [PMC free article] [PubMed] [Google Scholar]
- Enzmann D. R., Donaldson S. S., Kriss J. P. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979 Dec;3(6):815–819. [PubMed] [Google Scholar]
- Forrester J. V., Sutherland G. R., McDougall I. R. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J Clin Endocrinol Metab. 1977 Aug;45(2):221–224. doi: 10.1210/jcem-45-2-221. [DOI] [PubMed] [Google Scholar]
- Franco P. S., Hershman J. M., Haigler E. D., Jr, Pittman J. A., Jr Response to thyrotropin-releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease. Metabolism. 1973 Nov;23(2):1357–1365. doi: 10.1016/0026-0495(73)90251-5. [DOI] [PubMed] [Google Scholar]
- Földes J. Euthyroid endocrine ophthalmopathy: a study of the pituitary-thyroid system. Acta Med Acad Sci Hung. 1975;32(3-4):217–222. [PubMed] [Google Scholar]
- Gamblin G. T., Harper D. G., Galentine P., Buck D. R., Chernow B., Eil C. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. N Engl J Med. 1983 Feb 24;308(8):420–424. doi: 10.1056/NEJM198302243080803. [DOI] [PubMed] [Google Scholar]
- Hall R., Kirkham K., Doniach D., el-Kabir D. Ophthalmic Graves' disease. Diagnosis and pathogenesis. Lancet. 1970 Feb 21;1(7643):375–378. doi: 10.1016/s0140-6736(70)91513-8. [DOI] [PubMed] [Google Scholar]
- McKenzie J. M. Humoral factors in the pathogenesis of Graves' disease. Physiol Rev. 1968 Jan;48(1):252–310. doi: 10.1152/physrev.1968.48.1.252. [DOI] [PubMed] [Google Scholar]
- Tamai H., Nakagawa T., Ohsako N., Fukino O., Takahashi H., Matsuzuka F., Kuma K., Nagataki S. Changes in thyroid functions in patients with euthyroid Graves' disease. J Clin Endocrinol Metab. 1980 Jan;50(1):108–112. doi: 10.1210/jcem-50-1-108. [DOI] [PubMed] [Google Scholar]
- Teng C. S., Yeo P. P. Ophthalmic Graves's disease: natural history and detailed thyroid function studies. Br Med J. 1977 Jan 29;1(6056):273–275. doi: 10.1136/bmj.1.6056.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werner S. C. Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol. 1977 May;83(5):725–727. doi: 10.1016/0002-9394(77)90140-4. [DOI] [PubMed] [Google Scholar]